Cargando…
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899535/ http://dx.doi.org/10.1016/S2666-6367(23)00506-7 |
| _version_ | 1784882657102921728 |
|---|---|
| author | Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda, Omar Elmariah, Hany Freeman, Ciara Hansen, Doris K Jain, Michael D Khimani, Farhad Lazaryan, Aleksandr Liu, Hien Locke, Frederick L. Mishra, Asmita Nieder, Dr. Michael L. Ochoa, Leonel Perez, Lia Elena Pidala, Joseph A. Quilitz, Rod Klinkova, Olga V Baluch, Aliyah Nishihori, Taiga Faramand, Rawan G |
| author_facet | Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda, Omar Elmariah, Hany Freeman, Ciara Hansen, Doris K Jain, Michael D Khimani, Farhad Lazaryan, Aleksandr Liu, Hien Locke, Frederick L. Mishra, Asmita Nieder, Dr. Michael L. Ochoa, Leonel Perez, Lia Elena Pidala, Joseph A. Quilitz, Rod Klinkova, Olga V Baluch, Aliyah Nishihori, Taiga Faramand, Rawan G |
| author_sort | Ionescu, Filip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9899535 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98995352023-02-06 Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda, Omar Elmariah, Hany Freeman, Ciara Hansen, Doris K Jain, Michael D Khimani, Farhad Lazaryan, Aleksandr Liu, Hien Locke, Frederick L. Mishra, Asmita Nieder, Dr. Michael L. Ochoa, Leonel Perez, Lia Elena Pidala, Joseph A. Quilitz, Rod Klinkova, Olga V Baluch, Aliyah Nishihori, Taiga Faramand, Rawan G Transplant Cell Ther Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023-02 2023-02-06 /pmc/articles/PMC9899535/ http://dx.doi.org/10.1016/S2666-6367(23)00506-7 Text en Copyright © 2023 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda, Omar Elmariah, Hany Freeman, Ciara Hansen, Doris K Jain, Michael D Khimani, Farhad Lazaryan, Aleksandr Liu, Hien Locke, Frederick L. Mishra, Asmita Nieder, Dr. Michael L. Ochoa, Leonel Perez, Lia Elena Pidala, Joseph A. Quilitz, Rod Klinkova, Olga V Baluch, Aliyah Nishihori, Taiga Faramand, Rawan G Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_full | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_fullStr | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_full_unstemmed | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_short | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_sort | outpatient treatment with anti-sars-cov-2 monoclonal antibodies and remdesivir for covid19 infections demonstrates encouraging outcomes in hematopoietic stem cell transplant recipients: a single-center experience |
| topic | Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899535/ http://dx.doi.org/10.1016/S2666-6367(23)00506-7 |
| work_keys_str_mv | AT ionescufilip outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT ajayieloho outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT leachaamia outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT alsinamelissa outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT bejanyannelli outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT castanedaomar outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT elmariahhany outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT freemanciara outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT hansendorisk outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT jainmichaeld outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT khimanifarhad outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT lazaryanaleksandr outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT liuhien outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT lockefrederickl outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT mishraasmita outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT niederdrmichaell outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT ochoaleonel outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT perezliaelena outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT pidalajosepha outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT quilitzrod outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT klinkovaolgav outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT baluchaliyah outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT nishihoritaiga outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT faramandrawang outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience |